Talkingmed

This week we review 1) Psoriasis: Parisi R, Webb RT, Carr MJ, Moriarty KJ, Kleyn CE, Griffiths CEM, Ashcroft DM. Alcohol-Related Mortality in Patients With Psoriasis: A Population-Based Cohort Study. JAMA Dermatol. Published online September 15, 2017. doi:10.1001/jamadermatol.2017.3225 https://www.aad.org/public/diseases/scaly-skin/psoriasis#medication 2) Stroke Medications: Hong K, Kwon SU, Lee SH, Lee JS, Kim Y, Song T, Kim YD, Park M, Kim E, Cha J, Sung SM, Yoon B, Bang OY, Seo W, Hwang Y, Ahn SH, Kang D, Kang HG, Yu K, for the Phase 2 Exploratory Clinical Study to Assess the Effects of Xarelto (Rivaroxaban) Versus Warfarin on Ischemia, Bleeding, and Hospital Stay in Acute Cerebral Infarction Patients With Non-valvular Atrial Fibrillation (Triple AXEL) Study Group. Rivaroxaban vs Warfarin Sodium in the Ultra-Early Period After Atrial Fibrillation–Related Mild Ischemic StrokeA Randomized Clinical Trial. JAMA Neurol. Published online September 11, 2017. doi:10.1001/jamaneurol.2017.2161 3) Healthcare in Pol